Lexeo Therapeutics, Inc. — Investor Relations & Filings
Lexeo Therapeutics, Inc. is a clinical-stage genetic medicine company dedicated to developing gene therapies for genetically defined diseases. The company is advancing a diverse pipeline of investigational adeno-associated virus (AAV)-based gene therapy candidates. Its primary areas of focus are rare cardiovascular diseases and APOE4-associated Alzheimer's disease. Lexeo's strategy centers on addressing conditions with high unmet medical needs by leveraging pioneering science, including research originating from institutions such as Weill Cornell Medicine, to develop treatments with curative potential.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-05-11 | English | |
| 8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-05-11 | English | |
| ARS - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-04-30 | English | |
| DEF 14A - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-04-30 | English | |
| 8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-04-30 | English | |
| 10-K - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-03-30 | English |
Browse filings by year
5 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Hindustan Bio Sciences Ltd.
Develops and distributes biotech-derived products and pharm…
|
532041 | IN | Manufacturing |
|
HINOVA PHARMACEUTICALS INC.
Clinical-stage developer of cancer and metabolic disease sm…
|
688302 | CN | Manufacturing |
|
Hin Sang Group (International) Holding Co. Ltd.
Develops and distributes children's healthcare, TCM, person…
|
6893 | HK | Manufacturing |
|
HISAMITSU PHARMACEUTICAL CO.,INC.
A pharmaceutical firm specializing in external pain relief …
|
4530 | JP | Manufacturing |
|
HK inno.N Corporation
A biohealth company developing pharmaceuticals and consumer…
|
195940 | KR | Manufacturing |
|
HLB Genex, Inc.
Develops and produces customized enzyme and microbiome-base…
|
187420 | KR | Manufacturing |
|
HLB INC.
A biopharmaceutical company developing new global anti-canc…
|
028300 | KR | Manufacturing |
|
HLB Life Science CO.,LTD.
Develops anti-cancer drugs and manufactures in vitro diagno…
|
067630 | KR | Manufacturing |
|
HLB Pep Co., Ltd.
Biopharmaceutical firm specializing in peptide-based drug R…
|
196300 | KR | Manufacturing |
|
HLB PHARMACEUTICAL CO., LTD.
Develops and manufactures pharmaceuticals, quasi-drugs, and…
|
047920 | KR | Manufacturing |
Lexeo Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33133/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33133 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33133 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33133 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33133}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lexeo Therapeutics, Inc. (id: 33133)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.